<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Vaccinations prior to or after solid organ transplant</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Vaccinations prior to or after solid organ transplant</h1>
<div class="graphic"><div class="figure"><div class="ttl">Vaccinations prior to or after solid organ transplant</div><div class="cntnt"><table cellspacing="0"><colgroup width="30%"></colgroup><colgroup span="4" width="17%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2">Vaccine</td> <td class="subtitle1" colspan="2">Pretransplant</td> <td class="subtitle1" colspan="2">Starting 2 to 6 months posttransplant</td> </tr> <tr> <td class="subtitle2">Recommendation</td> <td class="subtitle2">Strength, evidence quality</td> <td class="subtitle2">Recommendation</td> <td class="subtitle2">Strength, evidence quality</td> </tr> <tr> <td><em>Haemophilus influenzae</em> b conjugate</td> <td>U</td> <td>Strong, moderate</td> <td>U</td> <td>Strong, moderate</td> </tr> <tr> <td>Hepatitis A</td> <td> <p>U: age 12 to 23 months</p> R: age ≥2 years</td> <td> <p>Strong, moderate</p> Strong, moderate</td> <td>R, if not completed pretransplant</td> <td>Strong, moderate</td> </tr> <tr> <td>Hepatitis B</td> <td> <p>U: age 1 to 18 years</p> R: age ≥18 years</td> <td> <p>Strong, moderate</p> Strong, moderate</td> <td>R, if not completed pretransplant*</td> <td>Strong, moderate</td> </tr> <tr> <td>Diphtheria toxoid, tetanus toxoid, acellular pertussis; tetanus toxoid, reduced diphtheria toxoid; tetanus toxoid, reduced diphtheria toxoid, and reduced acellular pertussis</td> <td>U</td> <td>Strong, moderate</td> <td>U, if not completed pretransplant</td> <td>Strong, moderate</td> </tr> <tr> <td>Human papillomavirus</td> <td> <p>U: females 11 to 26 years</p> U: males 11 to 26 years</td> <td> <p>Strong, moderate</p> Strong, low</td> <td> <p>U: females 11 to 26 years</p> U: males 11 to 26 years</td> <td> <p>Strong, moderate</p> Strong, low</td> </tr> <tr> <td>Influenza-inactivated (inactivated influenza vaccine)</td> <td>U</td> <td>Strong, moderate</td> <td>U<sup>¶</sup></td> <td>Strong, moderate</td> </tr> <tr> <td>Influenza-live attenuated (live attenuated influenza vaccine)</td> <td>X</td> <td>Weak, low</td> <td>X</td> <td>Weak, low</td> </tr> <tr> <td>Measles, mumps, and rubella-live</td> <td> <p>R<sup>Δ</sup>: age 6 to 11 months</p> U<sup>◊</sup>: age ≥12 months</td> <td> <p>Weak, very low</p> Strong, moderate</td> <td>X</td> <td>Strong, low</td> </tr> <tr> <td>Measles, mumps, and rubella-varicella-live</td> <td>U<sup>◊</sup></td> <td>Strong, moderate</td> <td>X</td> <td>Strong, low</td> </tr> <tr> <td>Meningococcal conjugate</td> <td>U</td> <td>Strong, moderate</td> <td>U</td> <td>Strong, moderate</td> </tr> <tr> <td>Pneumococcal conjugate (PCV13)</td> <td> <p>U: age ≤5 years</p> R: age ≥6 years<sup>§</sup></td> <td> <p>Strong, moderate</p> Strong, very low</td> <td> <p>U: age 2 to 5 years</p> R: age ≥6 years if not administered pretransplant<sup>§</sup></td> <td> <p>Strong, moderate</p> Strong, very low</td> </tr> <tr> <td>Pneumococcal polysaccharide (PPSV23)</td> <td>R: age ≥2 years</td> <td>Strong, moderate</td> <td>R: age ≥2 years, if not administered pretransplant</td> <td>Strong, moderate</td> </tr> <tr> <td>Polio-inactivated (inactivated poliovirus vaccine)</td> <td>U</td> <td>Strong, moderate</td> <td>U</td> <td>Strong, moderate</td> </tr> <tr> <td>Rotavirus-live</td> <td>U<sup>Δ</sup></td> <td>Strong, moderate</td> <td>X</td> <td>Strong, low</td> </tr> <tr> <td>Varicella-live</td> <td> <p>R<sup>¥</sup>: age 6 to 11 months</p> U<sup>◊</sup></td> <td> <p>Weak, very low</p> Strong, low</td> <td>X<sup>‡</sup></td> <td>Strong, low</td> </tr> <tr> <td>Zoster vaccination<sup>†</sup></td> <td> <p>R**: age 50 to 59 years</p> U<sup>¶¶</sup>: age ≥60 years</td> <td> <p>Weak, low</p> Strong, moderate</td> <td>X</td> <td>Strong, low</td> </tr> </tbody></table></div><div class="graphic_footnotes">R: recommended - administer if not previously administered or not current; such patients may be at increased risk for this vaccine-preventable infection; U: usual - administer if patient not current with annually updated United States Centers for Disease Control and Prevention (CDC) recommendations for immunocompetent persons in risk and age categories; X: contraindicated.<br/>* Consider hepatitis B vaccine for hepatitis B-infected liver transplant patients (weak, low).<br/>¶ Inactivated influenza vaccine may be administered to solid organ transplant recipients despite intensive immunosuppression (eg, during the immediate posttransplant period), particularly in an outbreak situation (weak, low).<br/>Δ Administer only if patient is not immunosuppressed and the timing is ≥4 weeks prior to transplant.<br/><font class="lozenge">◊</font> Administer only if patient is nonimmune, not severely immunosuppressed, and the timing is ≥4 weeks prior to transplant.<br/>§ For patients aged ≥19 years who have received PPSV23, PCV13 should be administered after an interval of ≥1 year after the last PPSV23 dose (weak, low).<br/>¥ Administer only if patient is not immunosuppressed and the timing is ≥4 weeks prior to transplant. This recommendation deviates from recommendations of the Advisory Committee on Immunization Practices, CDC.<br/>‡ Selected seronegative patients with renal or liver transplant have been safely vaccinated. This recommendation deviates from recommendations of the Advisory Committee on Immunization Practices, CDC.<br/>† Two zoster vaccine formulations are available: the recombinant varicella zoster vaccine and the live zoster vaccine. Either can be given prior to transplantation, provided the interval between vaccination and transplantation is sufficient. Neither is recommended after transplantation or for immunocompromised patients in general. Refer to the UpToDate topic on vaccination for the prevention of shingles for detail.<br/>** Administer only if patient is not severely immunosuppressed, the timing is ≥4 weeks prior to transplant, and the patient is varicella immune as defined by documentation of age-appropriate varicella vaccination, serologic evidence of immunity, documentation of varicella or zoster infection, or birth in the United States before 1980<sup>[1,2]</sup>. This recommendation deviates from recommendations of the Advisory Committee on Immunization Practices, CDC.<br/>¶¶ Administer only if patient is not severely immunosuppressed and the timing is ≥4 weeks prior to transplant.</div><div class="graphic_reference">References: 

<ol>
<li>Marin M, Guris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1.</li>
<li>Kotton CN, Hibberd PL. Travel medicine and the solid organ transplant recipient. Am J Transplant 2009; 9 (Suppl 4):S273.</li></ol>Reproduced from: Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2013; 58:e44. By permission of the Infectious Disease Society of America. Copyright © 2013 Oxford University Press. Available at: <a href="https://www.idsociety.org/practice-guideline/vaccination-of-the-immunocompromised-host/" target="_blank">https://www.idsociety.org/practice-guideline/vaccination-of-the-immunocompromised-host/</a>.</div><div id="graphicVersion">Graphic 91883 Version 21.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
